Skip to main content
Log in

Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis

  • Review
  • Published:
Pathology & Oncology Research

Abstract

Hepatocellular carcinoma (HCC), the major manifestation of primary liver cancer, is one of the most frequent and malignant diseases worldwide. Among other environmental factors, hepatitis viruses, as the hepatitis B (HBV) and hepatitis C (HCV) viruses, are to be listed in the etiology of HCC. Both of these viruses cause a wide spectrum of clinical manifestations, ranging from healthy carrier state to acute and chronic hepatitis, cirrhosis and HCC. HBV and HCV are different viruses in structure: HBV contains a DNA genome which replicates through an RNA intermediate and requires an active viral reverse transcriptase (RT) polymerase enzyme, while HCV is an RNA virus which has no RT activity and replicates on the cellular membrane by RNA replication. In this review we discuss how these two biologically diverse viruses use common pathways to induce hepatocarcinogenesis despite their significant structural and viral cycle differences. A summary is also given of several observable common and different features. Direct integration of HBV viral sequences into the host genome increases the genomic instability, which does not occur in HCV infection. However, viral proteins may directly play a significant role in the induction of carcinogenesis by both viruses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

STAT 3:

signal transducer and activator of transcription 3

IGF:

insulin-like growth factor

PKC:

protein kinase C

NFB:

nuclear factor kappa

References

  1. Agnello V, Abel G, Elfahal M et al: Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96: 12766–12771, 1999

    Article  PubMed  CAS  Google Scholar 

  2. Aizawa Y, Shibamoto Y, Takagi I et al: Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. Cancer 89: 53–59, 2000

    CAS  Google Scholar 

  3. Andrisani OM, Barnabas S: The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int J Oncol 15: 373–379, 1999

    PubMed  CAS  Google Scholar 

  4. Anthony PP: Hepatocellular carcinoma: an overview. Histopathology 39: 109–118, 2001

    Article  PubMed  CAS  Google Scholar 

  5. Bosch FX: Global epidemiology of hepatocellular carcinoma. In: Liver Cancer. (Eds: Okuda K, Tabor E), Churchill Livingstone, New York, 1997, pp. 13–28

    Google Scholar 

  6. Bréchot C, Gozuacik D, Murakami Y et al: Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol 10: 211–231, 2000

    Article  PubMed  CAS  Google Scholar 

  7. Buendia MA: Genetics of hepatocellular carcinoma. Semin Cancer Biol 10: 185–200, 2000

    Article  PubMed  CAS  Google Scholar 

  8. Chen P-J, Chen D-S: Hepatitis B virus infection and hepatocellular carcinoma: Molecular genetics and clinical perspectives. Semin Liver Dis 19: 253–262, 1999

    PubMed  CAS  Google Scholar 

  9. Cohen J: The scientific challenge of hepatitis C. Science 285: 26–30, 1999

    Article  PubMed  CAS  Google Scholar 

  10. Conjeevaram HS, Lok AS: Management of chronic hepatitis B. J Hepatol 38: S90-S103, 2003

    Article  PubMed  Google Scholar 

  11. Edamoto Y, Hara A, Biernat W et al: Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer 106: 334–341, 2003

    Article  PubMed  CAS  Google Scholar 

  12. El-Serag HB, Mason AC, Key C: Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 3: 62–65, 2001

    Article  Google Scholar 

  13. Faivre J, Forman D, Estève J et al: Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group. Eur J Cancer 34: 2184–2190, 1998

    Article  CAS  Google Scholar 

  14. Feitelson MA: Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol 181: 188–202, 1999

    Article  PubMed  CAS  Google Scholar 

  15. Feo F, Pascale RM, Simile MM et al: Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit Rev Oncogen 11: 19–62, 2000

    CAS  Google Scholar 

  16. Ferber MJ, Montoya DP, Yu C et al: Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (h TERT) gene in liver and cervical cancers. Oncogene 22: 3813–3820, 2003

    Article  PubMed  CAS  Google Scholar 

  17. Ferlay J, Bray F, Pisani P et al: GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, Version 1.0., IARC CancerBase No. 5, IARC Press, Lyon, 2001

    Google Scholar 

  18. Gelatti U, Donato F, Tagger A et al: Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol 98: 907–914, 2003

    Article  PubMed  Google Scholar 

  19. Giannelli G, Fransvea E, Marinosci F et al: Transforming growth factor-1 triggers hepatocellular carcinoma invasiveness via 31 integrin. Am J Pathol 161: 183–193, 2002

    PubMed  CAS  Google Scholar 

  20. Idilman R, DeMaria N, Colantoni A et al: Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepat 5: 285–299, 1998

    Article  PubMed  CAS  Google Scholar 

  21. Iizuka N, Oka M, Yamada-Okabe H et al: Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 22: 3007–3014, 2003

    Article  PubMed  CAS  Google Scholar 

  22. Laurent-Puig P, Legoix P, Bluteau O et al: Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120: 1763–1773, 2001

    Article  PubMed  CAS  Google Scholar 

  23. Moradpour D, Wands JR: Molecular pathogenesis of hepatocellular carcinoma. In: Hepatology. A Textbook of Liver Disease, ed 4. (Eds: Zakim D, Boyer TD), Saunders, Philadelphia, 2003, pp. 1333–1354

    Google Scholar 

  24. Nair S, Perrillo RP: Hepatitis B and D. In: Hepatology. A Textbook of Liver Disease, ed 4. (Eds: Zakim D, Boyer TD), Saunders, Philadelphia, 2003, pp. 959–1016

    Google Scholar 

  25. Nakamoto Y, Kanekos S: Mechanisms of viral hepatitis induced liver injury. Curr Mol Med 3: 537–544, 2003

    Article  PubMed  CAS  Google Scholar 

  26. Ochiai T, Urata Y, Yamano T et al: Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X-chromosome locus. Hepatology 31: 615–621, 2000

    Article  PubMed  CAS  Google Scholar 

  27. Okuda K: Hepatocellular carcinoma. J Hepatol 32 (Suppl 1): 225–237, 2000

    Article  PubMed  CAS  Google Scholar 

  28. Ozturk M: Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 19: 235–242, 1999

    PubMed  CAS  Google Scholar 

  29. Paradis V, Bièche I, Dargère D et al: Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach. Am J Pathol 163: 733–741, 2003

    PubMed  CAS  Google Scholar 

  30. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 37: S4-S66, 2001

    Article  PubMed  Google Scholar 

  31. Pileri P, Uematsu Y, Campagnoli S et al: Binding of hepatitis C virus to CD81. Science 282: 938–941, 1998

    Article  PubMed  CAS  Google Scholar 

  32. Pina Dore M, Realdi G, Mura D et al: Genomic instability in chronic viral hepatitis and hepatocellular carcinoma. Hum Pathol 32: 698–703, 2001

    Article  Google Scholar 

  33. Pineau P andBuendia MA: Studies of genetic defects in hepatocellular carcinoma: recent outcomes and new challenges. J Hepatol 33: 152–156, 2000

    Article  PubMed  CAS  Google Scholar 

  34. Poussin K, Dienes H, Sirma H et al: Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer 80: 497–505, 1999

    Article  PubMed  CAS  Google Scholar 

  35. Qui W, David D, Zhou B et al: Down-regulation of growth arrest DNA damage-inducible gene 45 expression is associated with human hepatocellular carcinoma. Am J Pathol 162: 1961–1974, 2003

    Google Scholar 

  36. Rosen HR, Gretch DR: Hepatitis C virus: current understanding and prospects for future therapies. Mol Med Today 5: 393–399, 1999

    Article  PubMed  CAS  Google Scholar 

  37. Saunier B, Triyatni M, Ulianich L et al: Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol 77: 546–559, 2003

    Article  PubMed  CAS  Google Scholar 

  38. Scarselli E, Ansuini H, Cerino R et al: The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21: 5017–5025, 2002

    Article  PubMed  CAS  Google Scholar 

  39. Schulze zur Wiesch J, Schmitz H, Borowski E, Borowski P: The proteins of the hepatitis C virus: Their features and interactions with intracellular protein phosphorylation. Arch Virol 148: 1247–1267, 2003

    PubMed  CAS  Google Scholar 

  40. Szabó E, Lotz G, Páska C et al: Viral hepatitis: New data on hepatitis C. Pathol Oncol Res 9: 215–221, 2003

    Article  PubMed  Google Scholar 

  41. Tabor E: Interferon for preventing and treating hepatocellular carcinoma associated with the hepatitis B and C viruses. Dig Liver Dis 35: 297–305, 2003

    Article  PubMed  CAS  Google Scholar 

  42. Thorgeirsson SS, Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339–346, 2002

    Article  PubMed  CAS  Google Scholar 

  43. Torbenson M, Marinopoulos S, Dang DT et al: Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling. Hum Pathol 33: 871–876, 2002

    Article  PubMed  CAS  Google Scholar 

  44. Tornillo L, Carafa V, Richter J et al: Marked genetic similarities between hepatitis B virus-positive and hepatitis C viruspositive hepatocellular carcinomas. J Pathol 192: 307–312, 2000

    Article  PubMed  CAS  Google Scholar 

  45. van Regenmortel MHV, Fauquet CM, Bishop DHL et al: Virus Taxonomy. The VIIth Report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, 2000

    Google Scholar 

  46. Wagayama, H, Shiraki K, Sugimoto K et al: High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases. Hum Pathol 33: 429–434, 2002

    Article  PubMed  CAS  Google Scholar 

  47. Waris G, Siddiqui A: Regulatory mechanisms of viral hepatitis B and C. J Biosci 28: 311–321, 2003

    PubMed  CAS  Google Scholar 

  48. Xu X-R, Huang J, Xu Z-G et al: Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98: 15089–15094, 2001

    Article  PubMed  CAS  Google Scholar 

  49. Ye Q-H, Qin L-X, Forgues M et al: Predicting hepatitis B viruspositive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9: 416–423, 2003

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zsuzsa Schaff.

Additional information

This work has been supported by grants Bio-00014/2001, ETT-077/2003, NKFP-1A/0023/2002 and OTKA T 037838

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szabó, E., Páska, C., Novák, P.K. et al. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol. Oncol. Res. 10, 5–11 (2004). https://doi.org/10.1007/BF02893401

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02893401

Keywords

Navigation